Vedolizumab 300mg, 108 mg/0.68 mL Suppliers & Bulk Manufacturers
Available Forms: Injection / infusion
Available Strengths: 300mg, 108 mg/0.68 mL
Reference Brands: ENTYVIO (USA/EU)
Category: Gastrointestinal Drugs
Vedolizumab is a gut-selective monoclonal antibody that blocks the α4β7 integrin, preventing white blood cells from migrating into inflamed gastrointestinal tissue. It is used to treat adults with moderate to severe ulcerative colitis or Crohn’s disease who have not responded adequately to conventional therapies. Entyvio is administered either as an intravenous infusion (300 mg) or subcutaneous injection (108 mg). The drug is known for its targeted mechanism that reduces systemic immunosuppression compared to other biologics.
Vedolizumab — third party manufacturing & bulk supply
Vedolizumab 300mg, 108 mg/0.68 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Vedolizumab is supplied as Injection / infusion — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Vedolizumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Vedolizumab →Frequently Asked Questions
Vedolizumab is used to treat moderate to severe ulcerative colitis and Crohn’s disease in adults. It helps reduce inflammation in the digestive tract and maintain remission by blocking the movement of inflammatory white blood cells (lymphocytes) into the gut, which are responsible for causing inflammation.
Vedolizumab is made from Vedolizumab, a humanized monoclonal antibody that targets the α4β7 integrin receptor on gut-specific lymphocytes, thereby preventing their migration to inflamed intestinal tissue.
The trade name of Vedolizumab is Entyvio.
Vedolizumab (En tyvio)is developed and manufactured by Takeda Pharmaceutical Company Limited, Japan, and marketed globally under regulatory approvals.
The generic name of Vedolizumab is Vedolizumab.
The brand name of Vedolizumab is Entyvio.
Vedolizumab is manufactured by Takeda Pharmaceutical Company in Japan and its production facilities in the United States and Europe under strict GMP guidelines.
Related Products
Docusate Sodium
Strength:
100mg
Form: Capsules
Reference Brands: Colace (USA), DulcoEase (EU/UK)
View Details
Teduglutide
Strength:
5 mg vial
Form: Injection
Reference Brands: Gattex (USA), Revestive (EU/UK)
View Details
Vibegron
Strength:
75 mg
Form: Tablets
Reference Brands: Gemtesa (USA), Obgemsa (EU/UK)
View Details
Simethicone With Dill Oil Solution 1%W/V+0.5% V/V
Strength:
1%w/v + 0.5% v/v
Form: Solution
Reference Brands:
View DetailsMagnesium Carbonate+Magnesium Trisilicate+Sodium Bicarbontate Syrup
Strength:
250mg+250mg+250mg
Form: Syrup
Reference Brands:
View DetailsQuick Response Guaranteed | Verified Suppliers
